Seres Therapeutics (MCRB) Stock Chart & Stock Price History $14.43 +0.35 (+2.49%) As of 01:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Seres Therapeutics Stock Price Performance The Seres Therapeutics (MCRB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 42.73%, with a year-to-date return of -13.17%. In the past month, the stock has increased 86.69%, reflecting recent market activity. As of the latest close, Seres Therapeutics traded at $14.08 with a market cap of $122.92 million and volume of 49,544 shares. Five years ago, the stock traded at a split-adjusted price of $90.80, representing a 84.11% decrease over that period. At the time, it had a market cap of $340.49 million and a volume of 50,460 shares. Receive MCRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+14.81%1 Month Performance+86.69%3 Month Performance+95.01%Year-To-Date Performance-13.17%1 Year Performance-42.73%5 Year Performance-84.11% MCRB Stock Chart for Friday, July, 18, 2025 MCRB Chart by TradingView Seres Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$13.97$14.08+0.79%$14.51$13.1949,544 shs$122.92 million07/16/2025$14.67$13.97-4.77%$14.77$13.8490,742 shs$121.96 million07/15/2025$14.85$14.67-1.21%$15.50$14.22167,421 shs$128.10 million07/14/2025$12.57$14.85+18.14%$15.98$12.08739,585 shs$129.64 million07/11/2025$12.35$12.57+1.78%$12.87$11.9956,671 shs$109.74 million07/10/2025$12.38$12.35-0.24%$12.75$11.9590,045 shs$107.82 million07/09/2025$11.60$12.38+6.72%$12.84$11.46190,458 shs$108.10 million07/08/2025$10.85$11.60+6.91%$11.65$10.7475,914 shs$101.27 million07/07/2025$11.36$10.85-4.45%$11.86$10.6790,267 shs$94.72 million07/04/2025$11.36$11.36$12.18$10.69107,170 shs$99.13 million Get the Latest News and Ratings for MCRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$10.86$11.36+4.56%$12.18$10.69107,170 shs$99.13 million07/02/2025$10.70$10.86+1.50%$11.32$10.3859,702 shs$94.81 million07/01/2025$11.11$10.70-3.69%$11.11$9.80192,898 shs$93.41 million06/30/2025$9.10$11.11+22.09%$11.58$9.01370,870 shs$96.99 million06/27/2025$9.51$9.10-4.31%$9.70$8.9178,176 shs$79.46 million06/26/2025$9.51$9.51$9.58$8.85100,331 shs$83.02 million06/25/2025$8.42$9.51+12.95%$9.78$8.17199,212 shs$83.02 million06/24/2025$7.42$8.42+13.48%$8.44$7.48106,377 shs$73.51 million06/23/2025$7.40$7.42+0.27%$7.62$7.1788,602 shs$64.78 million06/20/2025$7.73$7.40-4.27%$7.82$7.3185,109 shs$64.60 million06/19/2025$7.73$7.73$7.89$7.2665,375 shs$67.48 million06/18/2025$7.32$7.73+5.60%$7.89$7.2665,375 shs$67.48 million06/17/2025$7.50$7.32-2.40%$7.54$7.2593,612 shs$63.92 million Related Companies RZLT Stock Chart ERAS Stock Chart TECX Stock Chart SLDB Stock Chart ITOS Stock Chart ETON Stock Chart ALT Stock Chart CMPX Stock Chart CYRX Stock Chart RVNC Stock Chart Receive MCRB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MCRB) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMiss This Window And You Miss EverythingThere’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the ph...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seres Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MCRB Stock Alerts